Monoclonal Antibody-Mediated Targeting of CD123, IL-3 Receptor α Chain, Eliminates Human Acute Myeloid Leukemic Stem Cells
Top Cited Papers
- 1 July 2009
- journal article
- Published by Elsevier BV in Cell Stem Cell
- Vol. 5 (1), 31-42
- https://doi.org/10.1016/j.stem.2009.04.018
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- Anti-CD38 antibody–mediated clearance of human repopulating cells masks the heterogeneity of leukemia-initiating cellsBlood, 2008
- Chemotherapy and Cancer Stem CellsCell Stem Cell, 2007
- Expression of interleukin-3 receptor subunits on defined subpopulations of acute myeloid leukemia blasts predicts the cytotoxicity of diphtheria toxin interleukin-3 fusion protein against malignant progenitors that engraft in immunodeficient miceBlood, 2006
- Immunophenotypic Features of Acute Myeloid Leukemias Overexpressing the Interleukin 3 Receptor Alpha ChainLeukemia & Lymphoma, 2004
- Human leukaemic stem cells: a novel target of therapyEuropean Journal of Clinical Investigation, 2004
- The phosphoserine-585–dependent pathway of the GM-CSF/IL-3/IL-5 receptors mediates hematopoietic cell survival through activation of NF-κB and induction of bcl-2Blood, 2004
- Expression and prognostic value of hemopoietic cytokine receptors in acute myeloid leukemia (AML): implications for future therapeutical strategiesEuropean Journal of Haematology, 2004
- Interleukin-3 receptor in acute leukemiaLeukemia, 2003
- RELATIONS BETWEEN IL-3-INDUCED PROLIFERATION AND IN VITRO CYTOKINE SECRETION OF BONE MARROW CELLS FROM AML PATIENTSCytokine, 1999
- Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cellNature Medicine, 1997